콜라겐으로 경구 관용을 유도한 관절염 동물 모델의 세포 특이적 면역 반응 조사

Oral administration of antigen has long been considered as a promising alternative for the treatment of chronic autoimmune diseases including rheumatoid arthritis (RA), and oral application of type II collagen (CII) has been proven to improve pathogenic symptoms in RA patients without problematic si...

Full description

Saved in:
Bibliographic Details
Published inImmune network Vol. 3; no. 2; pp. 136 - 144
Main Authors 민소연(So-Youn Min), 황수연(Sue-Yun Hwang), 이재선(Jae-sun Lee), 김주영(Ju-Young Kim), 이강은(Kang-Eun Lee), 김경운(Kyung-Wun Kim), 김영훈(Young-Hun Kim), 도주호(Ju-Ho Do), 김호연(Ho-Youn Kim)
Format Journal Article
LanguageKorean
Published 대한면역학회 2003
Subjects
Online AccessGet full text
ISSN1598-2629
2092-6685

Cover

Abstract Oral administration of antigen has long been considered as a promising alternative for the treatment of chronic autoimmune diseases including rheumatoid arthritis (RA), and oral application of type II collagen (CII) has been proven to improve pathogenic symptoms in RA patients without problematic side effects. To further current understandings about the immune suppression mechanisms mediated by orally administered antigens, we examined the changes in IgG subtypes, T-cell proliferative response, and proportion of interleukin (IL)-10 producing Th subsets in a time course study of collagen induced arthritis (CIA) animal models. We found that joint inflammation in CIA mouse peaked at 5 weeks after first immunization with CII, which was significantly subdued in mice pre-treated by repeated oral administration of CII. Orally tolerized mice also showed increase in their serum level of IgG1, while the level of IgG2a was decreased. T-cell proliferation upon CII stimulation was also suppressed in lymph nodes of mice given oral administration of CII compared to non-tolerized controls. When cultured in vitro in the presence of CII, T-cells isolated from orally tolerized mice presented higher proportion of $CD4^+IL-10^+$ subsets compared to non-tolerized controls. Interestingly, such increase in IL-10 producing cells were obvious first in Peyer's patch, then by 5 weeks after immunization, in mesenteric lymph node and spleen instead. This result indicates that a particular subset of T-cells with immune suppressive functions might have migrated from the original contact site with CII to inflamed joints via peripheral blood after 5 weeks post immunization.
AbstractList Oral administration of antigen has long been considered as a promising alternative for the treatment of chronic autoimmune diseases including rheumatoid arthritis (RA), and oral application of type II collagen (CII) has been proven to improve pathogenic symptoms in RA patients without problematic side effects. To further current understandings about the immune suppression mechanisms mediated by orally administered antigens, we examined the changes in IgG subtypes, T-cell proliferative response, and proportion of interleukin (IL)-10 producing Th subsets in a time course study of collagen induced arthritis (CIA) animal models. We found that joint inflammation in CIA mouse peaked at 5 weeks after first immunization with CII, which was significantly subdued in mice pre-treated by repeated oral administration of CII. Orally tolerized mice also showed increase in their serum level of IgG1, while the level of IgG2a was decreased. T-cell proliferation upon CII stimulation was also suppressed in lymph nodes of mice given oral administration of CII compared to non-tolerized controls. When cultured in vitro in the presence of CII, T-cells isolated from orally tolerized mice presented higher proportion of $CD4^+IL-10^+$ subsets compared to non-tolerized controls. Interestingly, such increase in IL-10 producing cells were obvious first in Peyer's patch, then by 5 weeks after immunization, in mesenteric lymph node and spleen instead. This result indicates that a particular subset of T-cells with immune suppressive functions might have migrated from the original contact site with CII to inflamed joints via peripheral blood after 5 weeks post immunization.
Author 황수연(Sue-Yun Hwang)
도주호(Ju-Ho Do)
김주영(Ju-Young Kim)
김경운(Kyung-Wun Kim)
민소연(So-Youn Min)
김영훈(Young-Hun Kim)
이강은(Kang-Eun Lee)
이재선(Jae-sun Lee)
김호연(Ho-Youn Kim)
Author_xml – sequence: 1
  fullname: 민소연(So-Youn Min)
– sequence: 2
  fullname: 황수연(Sue-Yun Hwang)
– sequence: 3
  fullname: 이재선(Jae-sun Lee)
– sequence: 4
  fullname: 김주영(Ju-Young Kim)
– sequence: 5
  fullname: 이강은(Kang-Eun Lee)
– sequence: 6
  fullname: 김경운(Kyung-Wun Kim)
– sequence: 7
  fullname: 김영훈(Young-Hun Kim)
– sequence: 8
  fullname: 도주호(Ju-Ho Do)
– sequence: 9
  fullname: 김호연(Ho-Youn Kim)
BookMark eNpFkE9LAkEAxYcwSK3vMJeOC7Mz7szsUcz-Sl68L-PuCJu2hVuHbhUeIgjrEFrsgt4yNhAxMNAvtDN-h6SCTr_H48c7vBzIBGeBXANZjGxsUMqtDMials0NTLG9AXJheIIQLRBmZUFTLyIVz9PJo47mahjBdLJIPxOYTq_160jHHaijgep2ls_RTze40705VN0Xlazw_qYeZjruQ92ZLbsJXN5_6XiqBzdQjaa69wHVuK_jJ6iHY32bbIL1hmiFcuuPeVDbLddK-0alundQKlaMJkXMoLje8CwpGcfIRLTObU8gzkm9wJiNBRaUYssT2MMN1zKlKQVzOeOSeZwS6TKSB9u_s00_vPCdwAtbzmHxqIoRIpiR1QeUUGL9e8Fl2z-Vni-c81UQ7SvnuLpTRpTYDFFGvgFCn4Ij
ContentType Journal Article
DBID DBRKI
TDB
JDI
DEWEY 616.97
DatabaseName DBPIA - 디비피아
DBpia
KoreaScience
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Medicine
DocumentTitle_FL Studies on the Cellular Immune Response in Animal Model of Arthritis after the Induction of Oral Tolerance
EISSN 2092-6685
EndPage 144
ExternalDocumentID JAKO200327362963635
NODE06397067
GroupedDBID 5-W
53G
8JR
8XY
9ZL
ACYCR
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DBRKI
DIK
E3Z
EF.
F5P
GW5
HYE
KQ8
KVFHK
M48
MZR
O5R
O5S
OK1
PGMZT
RPM
TDB
ZZE
.UV
JDI
M~E
ID FETCH-LOGICAL-k607-62bfd5ee7820106b89da0883b47792a2a6625da2d2fc51e1ea7c878e7d863ec73
ISSN 1598-2629
IngestDate Fri Dec 22 11:59:06 EST 2023
Thu Mar 13 19:40:02 EDT 2025
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords type II collagen
interferon-gamma ( $IFN-{\gamma}$)
interleukin-10 (IL-10)
Oral tolerance
rheumatoid arthritis
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k607-62bfd5ee7820106b89da0883b47792a2a6625da2d2fc51e1ea7c878e7d863ec73
Notes KISTI1.1003/JNL.JAKO200327362963635
OpenAccessLink http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO200327362963635&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01
PageCount 9
ParticipantIDs kisti_ndsl_JAKO200327362963635
nurimedia_primary_NODE06397067
PublicationCentury 2000
PublicationDate 2003
PublicationDateYYYYMMDD 2003-01-01
PublicationDate_xml – year: 2003
  text: 2003
PublicationDecade 2000
PublicationTitle Immune network
PublicationTitleAlternate Immune network : official journal of the Korean association of immunobiologists
PublicationYear 2003
Publisher 대한면역학회
Publisher_xml – name: 대한면역학회
SSID ssj0064375
ssib053376730
Score 1.5183977
Snippet Oral administration of antigen has long been considered as a promising alternative for the treatment of chronic autoimmune diseases including rheumatoid...
SourceID kisti
nurimedia
SourceType Open Access Repository
Publisher
StartPage 136
Title 콜라겐으로 경구 관용을 유도한 관절염 동물 모델의 세포 특이적 면역 반응 조사
URI https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE06397067
http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO200327362963635&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2092-6685
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064375
  issn: 1598-2629
  databaseCode: 5-W
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNSCqAfxEz9LDs5pieRzMnNMNltqpe3BivW0ZDezIpWt2C6iJ5UeRJDqQVplF9qblRVLqVCh_UOb9D_45mWypir4cUmGN-9r3stk3ptMZjTtGrVYTH27YbhOs2W4zIyN2OGWAUOnZbJW7DD09NQ0nbjtTs55cyNHvpRWLXWWGtebT3_7X8n_eBVg4Ff5l-w_eHbIFABQBv_CFTwM17_yMalVSRgRXiW1kPCIhFAISGgTbsoqgIdYFVhQrqg6IJAFjwQK5MrVDhI9IAHHQkSYW1EcAlNyYOMAIjWQ5Q1ZFXSAwRhi-yCvotA5R8nVAhQAd4Z1oCdTYjhDMcBagiJJh1pBCQQUyoAkJcbKWXEFAoFBhKDQBF4FUwuZQqND1I_ZRG0wqYLwG_KfGFFp5yvgi0cOOY-jxYCGElYt2mRCFH5rwZAvxsoUTqT8oIlkQ3OzgRE4O0TTEcZdoJl4jJPyJapSs3hNGik3QiCpJmNhLAIVLpEq0aBBlMUdpSbIY5ak6aB29yp4ODY_NJXjDLsdWr-KPJQjf7VmUcWxEAB-edji0DOo4i8QZpvcNijND0Qqxjqn1KXt0rhlObQUAln5lpw_bUQ-PRPV8DswBDgQ80BkK49K8Yw7xfsbMgef-jIdzSMh-U3Yw_2KlXaQAMqs6P4J7Vi7I0-vgFdgKZqbPaWdVGmYHuR96rQ2Mr9wRjuaH8z65Kw2n-13097eYPtN1t1LN7r6YHt_8LWvD3aeZR82s96ynnXX05Xlg3ddhK2_zFb39HTlfdqH26eP6evdrLemZ8u7Byt9_eDVt6y3k60_19PNnWz1s55urWW9t3q2sZW96J_TZsdrs9UJQx1LYsxT0zeo3WglnhByo0nLpA3GkxiGaqfh-j63Yzum1PaS2E7sVtOzhCViv8l8JvyEUUc0fee8NtpeaIsLms4hW0t4yxRyg27fBcYW92xh-gnkVa7nX9TG0F71drL4oD4Z3JyRTw0kHGBL6kCqAAhDQ9Yf5tvT1Mt-uvQnhMvacVyeipOKV7TRpUcdcRXC7KXGGPr2Ow1GtQo
linkProvider Korean Association of Medical Journal Editors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EC%BD%9C%EB%9D%BC%EA%B2%90%EC%9C%BC%EB%A1%9C+%EA%B2%BD%EA%B5%AC+%EA%B4%80%EC%9A%A9%EC%9D%84+%EC%9C%A0%EB%8F%84%ED%95%9C+%EA%B4%80%EC%A0%88%EC%97%BC+%EB%8F%99%EB%AC%BC+%EB%AA%A8%EB%8D%B8%EC%9D%98+%EC%84%B8%ED%8F%AC+%ED%8A%B9%EC%9D%B4%EC%A0%81+%EB%A9%B4%EC%97%AD+%EB%B0%98%EC%9D%91+%EC%A1%B0%EC%82%AC&rft.jtitle=Immune+network&rft.au=%EB%AF%BC%EC%86%8C%EC%97%B0%28So-Youn+Min%29&rft.au=%ED%99%A9%EC%88%98%EC%97%B0%28Sue-Yun+Hwang%29&rft.au=%EC%9D%B4%EC%9E%AC%EC%84%A0%28Jae-sun+Lee%29&rft.au=%EA%B9%80%EC%A3%BC%EC%98%81%28Ju-Young+Kim%29&rft.date=2003&rft.pub=%EB%8C%80%ED%95%9C%EB%A9%B4%EC%97%AD%ED%95%99%ED%9A%8C&rft.issn=1598-2629&rft.eissn=2092-6685&rft.volume=3&rft.issue=2&rft.spage=136&rft.epage=144&rft.externalDocID=NODE06397067
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2629&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2629&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2629&client=summon